Sort
30,917 grants matching “tumor microenvironment”
Tumor-stromal interactions as targets of tumor metastasis suppressors
$350,689Marsha R Rosner · University Of Chicago · R01 · FY2018 · CA
Measuring Signaling Pathway Dynamics During Tissue Growth in Hydrogels
$350,688Jacqueline Sara Jeruss · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Project 3: Sex-specific differences in the tumor microenvironment alter glioblastoma growth
$350,652Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2024 · CA
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
$350,644Marxa L. Figueiredo · Purdue University · R01 · FY2017 · CA
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor
$350,628Joanna B Kitlinska · Georgetown University · R01 · FY2015 · CA
Modeling and targeting tumor-immune signaling interactions in tumor microenvironment
$350,626Fuhai Li · Washington University · R01 · FY2023 · LM
Project 1: Targeting Metabolic Vulnerabilities in Lung Cancer
$350,616Ralph J Deberardinis · Ut Southwestern Medical Center · P50 · FY2024 · CA
Role of Adenosine in TGF-beta Effects in Cancers
$350,581Sergey V. Novitskiy · Vanderbilt University Medical Center · R01 · FY2019 · CA
The role of GPSM3 in tumor-promoting emergency myelopoiesis
$350,581Bin Zhang · Northwestern University At Chicago · R01 · FY2019 · CA
Strategies to improve outcomes for TNBC patients that integrate subtype-specific genomic and immune-based discoveries
$350,547Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2020 · CA
Ultra-Small Epigenetic-Regulating Nanocarrier for Enhanced Synthetic Lethal Therapy
$350,518Jingjing Sun · University Of Nebraska Medical Center · R01 · FY2025 · CA
Cannabinoid CB2 Agonists for Treatment of Breast Cancer Induced Bone Pain
$350,481Todd W Vanderah · University Of Arizona · R01 · FY2017 · CA
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
$350,460Kian H Lim · Washington University · R37 · FY2023 · CA
Pharmacological targeting of the Unfolded Protein Response as an antitumor strate
$350,444Constantinos Koumenis · University Of Pennsylvania · R01 · FY2010 · CA
Ras-mediated signals in human epithelial cell transformation and metastasis
$350,410Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Anti-Tumor Mechanisms of Intratumoral Stimulatory Dendritic Cells
$350,398Matthew F Krummel · University Of California, San Francisco · R01 · FY2017 · CA
MOLECULAR ONCOLOGY TRAINING GRANT
$350,387Lee Ratner · Washington University · T32 · FY2022 · CA
Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacy
$350,377Trisha M Wise-Draper · University Of Cincinnati · U01 · FY2023 · CA
Nutrient regulation of cancer cell growth
$350,353Heather Christofk · University Of California Los Angeles · R01 · FY2020 · CA
Label-Free, Longitudinal, Multi-Metric Viability Imaging of 3D Tissue Spheroid Array
$350,349Jonghwan Lee · Brown University · R01 · FY2021 · CA
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer
$350,268Martin G Pomper · Johns Hopkins University · U54 · FY2022 · CA
Project 2: Determinants of Response and Resistance to DNA-Damaging Radiation Plus Immunotherapy Combinations in Triple Negative Breast Cancer
$350,219Gaorav P. Gupta · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Data Analysis Unit
$350,212Kai Tan · Children'S Hosp Of Philadelphia · U2C · FY2021 · CA
Neuroimmunomodulation within the eye
$350,185Andrew W Taylor · Schepens Eye Research Institute · R01 · FY2008 · EY
Understanding functional roles and regulation of granzymes
$350,180Euna Yoo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA